Filing Details

Accession Number:
0001209784-17-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-13 16:39:54
Reporting Period:
2017-02-09
Filing Date:
2017-02-13
Accepted Time:
2017-02-13 16:39:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1116463 Orasure Technologies Inc OSUR Surgical & Medical Instruments & Apparatus (3841) 364370966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295391 A Douglas Michels 220 East First Street
Bethlehem PA 18015
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-09 90,990 $2.81 859,048 No 4 M Direct
Common Stock Acquisiton 2017-02-09 102,365 $5.19 961,413 No 4 M Direct
Common Stock Disposition 2017-02-09 90,990 $10.14 870,423 No 4 S Direct
Common Stock Disposition 2017-02-09 102,365 $10.27 768,058 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonqualified stock option Disposition 2017-02-09 90,990 $0.00 90,990 $2.81
Common Stock Nonqualified stock option Disposition 2017-02-09 102,365 $0.00 102,365 $5.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-01-23 No 4 M Direct
0 2020-01-25 No 4 M Direct
Footnotes
  1. Nonqualified stock options granted on January 23, 2009 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
  2. Nonqualified stock options granted on January 25, 2010 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
  3. Sale pursuant to a predetermined sales plan, entered into on August 22, 2016, under Rule 10b5-1 of the Securities and Exchange Act of 1934.